QT Imaging Holdings Announces Shipment of Six QT Breast Acoustic CT Scanners in the First Quarter of 2025
QT Imaging Holdings (OTCQB:QTIH) has announced the successful shipment of six QT Breast Acoustic CT™ Systems in Q1 2025, generating total revenue of $2.7 million. The company met its previously projected targets, marking a significant milestone in its commercial expansion.
The achievement underscores the success of QTIH's strategic partnership with NXC Imaging, Inc. and reinforces their position in the breast imaging market. The company aims to continue advancing its product offerings and expanding its presence in the medical imaging industry.
QT Imaging Holdings (OTCQB:QTIH) ha annunciato la spedizione con successo di sei sistemi QT Breast Acoustic CT™ nel primo trimestre del 2025, generando un fatturato totale di 2,7 milioni di dollari. L'azienda ha raggiunto gli obiettivi precedentemente previsti, segnando un traguardo significativo nella sua espansione commerciale.
Questo risultato sottolinea il successo della partnership strategica di QTIH con NXC Imaging, Inc. e rafforza la loro posizione nel mercato dell'imaging mammario. L'azienda mira a continuare a sviluppare la propria offerta di prodotti e ad ampliare la propria presenza nel settore dell'imaging medico.
QT Imaging Holdings (OTCQB:QTIH) ha anunciado el envío exitoso de seis sistemas QT Breast Acoustic CT™ en el primer trimestre de 2025, generando un ingreso total de 2,7 millones de dólares. La empresa cumplió con sus objetivos proyectados anteriormente, marcando un hito significativo en su expansión comercial.
Este logro subraya el éxito de la asociación estratégica de QTIH con NXC Imaging, Inc. y refuerza su posición en el mercado de imagenología mamaria. La empresa tiene como objetivo continuar avanzando en su oferta de productos y expandiendo su presencia en la industria de imagenología médica.
QT Imaging Holdings (OTCQB:QTIH)는 2025년 1분기에 여섯 대의 QT Breast Acoustic CT™ 시스템을 성공적으로 배송했다고 발표했으며, 총 수익은 270만 달러에 달합니다. 이 회사는 이전에 예상한 목표를 달성하여 상업적 확장에서 중요한 이정표를 세웠습니다.
이 성과는 QTIH와 NXC Imaging, Inc. 간의 전략적 파트너십의 성공을 강조하며, 유방 이미징 시장에서의 입지를 강화합니다. 이 회사는 제품 제공을 계속 발전시키고 의료 이미징 산업에서의 입지를 확대할 계획입니다.
QT Imaging Holdings (OTCQB:QTIH) a annoncé l'expédition réussie de six systèmes QT Breast Acoustic CT™ au premier trimestre 2025, générant un chiffre d'affaires total de 2,7 millions de dollars. L'entreprise a atteint ses objectifs précédemment projetés, marquant une étape significative dans son expansion commerciale.
Cette réalisation souligne le succès du partenariat stratégique de QTIH avec NXC Imaging, Inc. et renforce leur position sur le marché de l'imagerie mammaire. L'entreprise vise à continuer d'avancer dans son offre de produits et à élargir sa présence dans l'industrie de l'imagerie médicale.
QT Imaging Holdings (OTCQB:QTIH) hat den erfolgreichen Versand von sechs QT Breast Acoustic CT™ Systemen im ersten Quartal 2025 angekündigt, was zu einem Gesamterlös von 2,7 Millionen Dollar führte. Das Unternehmen hat seine zuvor projizierten Ziele erreicht und damit einen bedeutenden Meilenstein in seiner kommerziellen Expansion gesetzt.
Dieser Erfolg unterstreicht die Wirksamkeit der strategischen Partnerschaft von QTIH mit NXC Imaging, Inc. und stärkt deren Position im Bereich der Brustbildgebung. Das Unternehmen hat sich zum Ziel gesetzt, seine Produktangebote weiterzuentwickeln und seine Präsenz in der medizinischen Bildgebung zu erweitern.
- Successfully shipped 6 QT Breast Acoustic CT™ Systems
- Generated $2.7 million in revenue
- Met Q1 2025 projected targets
- None.
“We are excited to announce the shipment of six QT Breast Acoustic CT™ Systems, a significant milestone in our plan to deliver in accordance with our projections for the first quarter of 2025. This achievement highlights the strength of our strategic partnership with NXC Imaging, Inc. and our continued commitment to providing innovative solutions for the breast imaging market. We look forward to further advancing our product offerings and expanding our reach in the medical imaging industry,” said Steve Choate, Chief Operations Officer of the Company.
About QT Imaging Holdings, Inc.
QT Imaging Holdings, Inc. is a public (OTCQB: QTIH) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the company’s website at www.qtimaging.com.
Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as “will,” and “expect,” or the negative thereof or comparable terminology, and include (without limitation) statements regarding the shipments by QT Imaging Holdings, projected financial statements for QT Imaging Holdings for the first quarter of 2025, plans for QT Imaging Holdings, new product development and introduction, and product sales growth and projected revenues. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. These risks include, but are not limited to: research results from the use of the QT Breast Acoustic CT™ Scanner, the ability of QT Imaging Holdings to sell and deploy the QT Breast Acoustic CT™ Scanner, the ability to extend product offerings into new areas or products, the ability to commercialize technology, unexpected occurrences that deter the full documentation and “bring to market” plan for products, trends and fluctuations in the industry, changes in demand and purchasing volume of customers, unpredictability of suppliers, the ability to attract and retain qualified personnel and the ability to move product sales to production levels. Additional factors that could cause actual results to differ are discussed under the heading “Risk Factors” and in other sections of QT Imaging Holding’s filings with the SEC, and in its other current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to QT Imaging Holdings as of the date hereof, and QT Imaging Holdings assumes no obligation to update any forward-looking statement.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250401957855/en/
For media inquiries, please contact:
Susan Schaffler
Head of Communications
Susan.Schaffler@qtimaging.com
Stas Budagov
Chief Financial Officer
Stas.Budagov@qtimaging.com
Source: QT Imaging Holdings, Inc.
FAQ
How much revenue did QTIH generate from QT Breast Acoustic CT shipments in Q1 2025?
How many QT Breast Acoustic CT Systems did QTIH ship in the first quarter of 2025?
Did QTIH meet its projected shipment targets for Q1 2025?
Who is QTIH's strategic partner for the QT Breast Acoustic CT Systems?
